BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10029291)

  • 1. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.
    Wong BC; Lam SK; Ching CK; Hu WH; Kwok E; Ho J; Yuen ST; Gao Z; Chen JS; Lai KC; Ong LY; Chen BW; Wang WH; Jiang XW; Hou XH; Lu JY
    J Gastroenterol Hepatol; 1999 Feb; 14(2):120-5. PubMed ID: 10029291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in south China.
    Wong BC; Lam SK; Ching CK; Hu WH; Ong LY; Chen BW; Gao Z; Chen JS; Jiang XW; Hou XH; Lu JY; Wang WH; Ho J; Yuen ST; Lai KC; Kwok E; Hui WM; Covacci A
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1295-302. PubMed ID: 10540043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
    Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
    Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China.
    Zhang DH; Zhou LY; Lin SR; Ding SG; Huang YH; Gu F; Zhang L; Li Y; Cui RL; Meng LM; Yan XE; Zhang J
    Chin Med J (Engl); 2009 Aug; 122(15):1759-63. PubMed ID: 19781321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori serology in patients with gastric carcinoma.
    Kuipers EJ; Gracia-Casanova M; Peña AS; Pals G; Van Kamp G; Kok A; Kurz-Pohlmann E; Pels NF; Meuwissen SG
    Scand J Gastroenterol; 1993 May; 28(5):433-7. PubMed ID: 8511504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Helicobacter pylori in Bhutan: the role of environment and Geographic location.
    Dorji D; Dendup T; Malaty HM; Wangchuk K; Yangzom D; Richter JM
    Helicobacter; 2014 Feb; 19(1):69-73. PubMed ID: 24102940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
    Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
    Leung WK; Wong IOL; Cheung KS; Yeung KF; Chan EW; Wong AYS; Chen L; Wong ICK; Graham DY
    Gastroenterology; 2018 Jul; 155(1):67-75. PubMed ID: 29550592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Helicobacter pylori a causal agent in gastric carcinoma?
    Takahashi S; Igarashi H; Ishiyama N; Nakamura K; Masubuchi N; Ozaki M; Saito S; Aoyagi T; Itoh T; Hirata I
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):144-9. PubMed ID: 8280936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer.
    Kato M; Asaka M; Shimizu Y; Nobuta A; Takeda H; Sugiyama T;
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():85-9. PubMed ID: 15298611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence.
    Rudi J; Müller M; von Herbay A; Zuna I; Raedsch R; Stremmel W; Räth U
    Scand J Gastroenterol; 1995 Oct; 30(10):958-63. PubMed ID: 8545615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.
    You WC; Zhang L; Gail MH; Ma JL; Chang YS; Blot WJ; Li JY; Zhao CL; Liu WD; Li HQ; Hu YR; Bravo JC; Correa P; Xu GW; Fraumeni JF
    Int J Epidemiol; 1998 Dec; 27(6):941-4. PubMed ID: 10024185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations.
    Ren Z; Borody T; Pang G; Dunkley M; Clancy R; Xia HH; Chu KM; Wong J; Wong BC
    Aliment Pharmacol Ther; 2005 Jan; 21(1):83-9. PubMed ID: 15644049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.
    Groves FD; Perez-Perez G; Zhang L; You WC; Lipsitz SR; Gail MH; Fraumeni JF; Blaser MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1091-4. PubMed ID: 12376512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.